poisar

Stock

Tenax Therapeutics, Inc. TENX

$2.18+2.35%

Overview

TENX market data

Price History

TENX price chart · 1M
O
2.17
H
2.22
L
2.11
C
2.18
Vol
69,298.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$2.17
Previous Close
$2.13
Day High
$2.22
Day Low
$2.11
52 Week High
$19.19
52 Week Low
$1.32
7 Day Return
+21.85%
30 Day Return
-86.24%
90 Day Return
-81.74%
1 Year Return
-82.93%
Daily Notional Volume
$150.7K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.34
Diluted earnings per share over the trailing twelve months.
Beta
0.97
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-10,115.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.31 – $19.40
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $64.9M · P/B 0.78 · P/S 1,317.05.

Company News

10 captured
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 25, 2026, 5:06 PM
Chardan Capital Downgrades Tenax Therapeutics to Neutral, Lowers Price Target to $5Benzinga · Aug 11, 2026, 4:02 PM
Guggenheim Maintains Buy on Tenax Therapeutics, Lowers Price Target to $4Benzinga · Aug 11, 2026, 2:19 PM
Evercore ISI Group Downgrades Tenax Therapeutics to In-Line, Lowers Price Target to $5Benzinga · Aug 11, 2026, 12:38 PM
William Blair Downgrades Tenax Therapeutics to Market PerformBenzinga · Aug 10, 2026, 8:30 PM
Crude Oil Surges 3%; Sionna Therapeutics Shares PlungeBenzinga · Aug 10, 2026, 4:19 PM
Tenax Therapeutics Stock Dives as It Faces Heart Drug Study SetbackBenzinga · Aug 10, 2026, 4:02 PM
US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 ResultsBenzinga · Aug 10, 2026, 1:40 PM
Tenax Therapeutics shares are trading lower after the company announced its Phase 3 LEVEL clinical trial evaluating TNX-103 did not meet its primary or key secondary endpoints.Benzinga · Aug 10, 2026, 12:36 PM
12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · Aug 10, 2026, 12:06 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock